Sahop, Alejandro D.

HRN: 26-43-12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2025
CEFTAZIDIME 1GM (VIAL)
07/16/2025
07/23/2025
IV
1gm
Q8h
CAP MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: